Want to see COO full AI Analyst Report?
COO Stock Chart & Stats
$70.06
-$0.81(-0.88%)
At close: 4:00 PM EST
$70.06
-$0.81(-0.88%)
Day’s Range― - ―
52-Week Range$58.89 - $89.83
Previous CloseN/A
Volume244.93K
Average Volume (3M)3.57M
Market Cap
$13.58B
Enterprise Value$15.01B
Total Cash (Recent Filing)$138.80M
Total Debt (Recent Filing)$2.46B
Price to Earnings (P/E)60.2
Beta0.54
Next Earnings
Sep 02, 2026EPS Estimate
1.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.18
Shares Outstanding195,030,620
10 Day Avg. Volume2,966,665
30 Day Avg. Volume3,571,047
Financial Highlights & Ratios
PEG Ratio-8.14
Price to Book (P/B)1.70
Price to Sales (P/S)3.42
P/FCF Ratio32.24
Enterprise Value/Market Cap1.11
Enterprise Value/Revenue3.55
Enterprise Value/Gross Profit5.51
Enterprise Value/Ebitda17.33
Forecast
1Y Price Target
$77.89Price Target Upside11.17% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)4.63
Revenue Forecast (FY)$4.31B
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthSizable equity base and moderate leverage (~0.30 D/E) provide durable financial flexibility. This supports investment in R&D, M&A, litigation funding and capital returns without stressing liquidity, helping the company execute strategy through cycles and preserve optionality over the next several years.
Market Leadership In LensesLeading market share and strength in daily silicone hydrogel lenses create sustainable competitive advantages: scale in manufacturing, distribution reach, and brand recognition. This supports pricing, new product rollout adoption and long-term organic growth across regions, supporting durable revenue base.
Clear FCF Targets & GuidanceManagement's multi-year free-cash-flow targets and FY2026 guidance indicate disciplined capital allocation and focus on cash generation. Sustained FCF supports debt reduction, reinvestment and potential returns to shareholders, anchoring long-term financial resilience and strategic optionality.
Bears Say
Margin DeteriorationMaterial step-down in net margins versus prior years signals weakening profitability quality. Persistently lower margins reduce internal reinvestment capacity and return on capital, increasing sensitivity to cost inflation or pricing pressure and lowering long-run earnings power if not reversed.
Weakened Cash ConversionSignificant decline in free cash flow and weaker operating cash conversion imply reduced cash earnings quality and higher working-capital needs. Persistently lower FCF constrains discretionary spending and strategic moves, reducing resilience to shocks and limiting long-term capital allocation flexibility.
Significant Litigation Cash DemandLarge litigation accrual and concentrated payouts in fiscal 2026 create lasting GAAP earnings volatility and redirect cash away from growth investments. Even if insured partially, these liabilities can depress reported results, tighten near-term liquidity and complicate execution of buybacks or M&A.
Cooper Co News
COO FAQ
What was Cooper Companies’s price range in the past 12 months?
Cooper Companies lowest stock price was $58.89 and its highest was $89.83 in the past 12 months.
What is Cooper Companies’s market cap?
Cooper Companies’s market cap is $13.58B.
When is Cooper Companies’s upcoming earnings report date?
Cooper Companies’s upcoming earnings report date is Sep 02, 2026 which is in 54 days.
How were Cooper Companies’s earnings last quarter?
Cooper Companies released its earnings results on Jun 04, 2026. The company reported $1.21 earnings per share for the quarter, beating the consensus estimate of $1.104 by $0.106.
Is Cooper Companies overvalued?
According to Wall Street analysts Cooper Companies’s price is currently Undervalued.
Does Cooper Companies pay dividends?
Cooper Companies pays a Semiannually dividend of $0.007 which represents an annual dividend yield of N/A. See more information on Cooper Companies dividends here
What is Cooper Companies’s EPS estimate?
Cooper Companies’s EPS estimate is 1.13.
How many shares outstanding does Cooper Companies have?
Cooper Companies has 195,030,620 shares outstanding.
What happened to Cooper Companies’s price movement after its last earnings report?
Cooper Companies reported an EPS of $1.21 in its last earnings report, beating expectations of $1.104. Following the earnings report the stock price went up 8.578%.
Which hedge fund is a major shareholder of Cooper Companies?
Currently, no hedge funds are holding shares in COO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cooper Co Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$77.89 (11.17% Upside)
$77.89 (11.17% Upside)
Blogger Sentiment
Bullish
COO Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 5.5M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 2.5%
Last 30 Days ▲ 2.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-5.24%
12-Months-Change
Fundamentals
Return on Equity
2.84%
Trailing 12-Months
Asset Growth
0.55%
Trailing 12-Months
Company Description
Cooper Companies
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
COO Company Deck
COO Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a generally positive operational and financial picture: record quarterly revenue and strong non-GAAP EPS, meaningful margin expansion, robust product-level growth (notably MiSight and CooperSurgical fertility), improved free cash flow and active strategic initiatives. However, material near-term headwinds create caution — a significant litigation settlement affecting GAAP results and concentrated cash outflows, Asia Pacific market softness tied to legacy product rationalization and consumer weakness (especially Japan/China), and expected short-term gross margin pressure from FX, tariffs and inventory optimization. Management balanced conservative guidance with a clear plan for capital allocation and strategic review progress, leaving the near-term outlook mixed but supported by strong execution and long-term cash-generation targets.View all COO earnings summariesCOO Net sales Breakdown
67.05% CooperVision
32.95% CooperSurgical
COO Stock 12 Month Forecast
Average Price Target
$77.89
▲(11.17% Upside)
Technical Analysis
Ownership Overview
0.60% Insiders
35.18% Mutual Funds
0.36% Other Institutional Investors
35.42% Public Companies and
Individual Investors